Improved immunogenicity following the third dose of BNT162b2 mRNA vaccine in heart transplant recipients.
Aviv Avraham ShaulOsnat Itzhaki Ben ZadokBinyamin Ben-AvrahamVicky YaariAlon BarsheshetAmos LeviHaim Ben ZviNoa Eliakim RazGalia AbedMiriam AbuhaziraMahmood Abu AkelIsrael MatsYaron D BaracDan AravotRan KornowskiTuvia Ben-GalPublished in: European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery (2022)
Third-dose booster of BNT162b2 vaccine significantly increased immunogenicity among HTx recipients who previously received a two-dose vaccine.